Partnering News

04.26.2016

AM‐Pharma receives FDA fast track designation for recAP in Acute Kidney Injury, and reports completion of first stage in Phase II trial

04.19.2016

AM-Pharma STOP-AKI Phase II trial nominated for “Most Innovative Clinical Trial Design” in 2016 CARE Awards

04.04.2016

Cancer Metabolism Company Metabomed Completes $18 Million Series A Financing

02.04.2016

UI strikes agreement with Pfizer Inc. to develop potential cystic fibrosis gene therapy

01.25.2016

La Jolla Institute receives $5 million gift from Pfizer

01.20.2016

King’s College London signs licence and research agreement with Pfizer Inc. in the field of gene therapy

01.13.2016

California Institute for Biomedical Research (Calibr) Enters Worldwide Strategic Collaboration with Pfizer Inc.

01.11.2016

Schrödinger Announces Research Collaboration with Pfizer Inc.

01.11.2016

HemoShear Therapeutics Announces Next Stage of Safety Collaboration with Pfizer Inc.

01.07.2016

PHILOGEN ANNOUNCES EXERCISE OF OPTIONS WITHIN THE LICENSE AGREEMENT WITH PFIZER INC. FOR THE DEVELOPMENT AND POTENTIAL COMMERCIALIZATION OF MULTIPLE ANTIBODY DRUG CONJUGATES (ADCs) AND TARGETED TECHNOLOGIES

01.07.2016

4D Molecular Therapeutics Announces Collaboration with Pfizer Inc. for Cardiac Gene Therapy Vector Discovery and Development

01.06.2016

Cortexyme Raises $15 Million Series A